Roger Adsett
Chief Commercial Officer, INSMED Inc.
Companies
- Definium TherapeuticsBoard member Jan 29, 2026 to now1
- INSMED IncChief operating officer Nov 20, 2019 to now2
- Landos Biopharma, Inc.Board member Mar 10, 2022 to May 23, 20243
- INSMED IncChief Commercial Officer Oct 4, 2016 to May 18, 20214
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- INSMED Inc INSM98,744 shares5$9.8M at $99.21Aug 10, 2026
- Definium Therapeutics DFTX3,555 shares6$122.0K at $34.31Jun 11, 2026
- Landos Biopharma, Inc.0 shares7Mar 10, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 10, 2026Sold 239,850 shares at $133.27 of INSMED Inc5
- Aug 10, 2026Exercised options 80,970 shares at $30.46 of INSMED Inc5
- Aug 10, 2026Exercised options 76,600 shares at $17.16 of INSMED Inc5
- Aug 10, 2026Exercised options 82,280 shares at $13.67 of INSMED Inc5
- Jun 11, 2026Granted 3,555 shares of Definium Therapeutics6
- Jun 3, 2026Sold 2,370 shares at $102.27 of INSMED Inc8
- May 13, 2026Sold 5,837 shares at $116.18 of INSMED Inc9
- Apr 1, 2026Sold 62,344 shares at $164.95 of INSMED Inc10
- Apr 1, 2026Sold 19,001 shares at $164.11 of INSMED Inc10
- Apr 1, 2026Sold 6,715 shares at $163.18 of INSMED Inc10
- Apr 1, 2026Exercised options 88,060 shares at $14.56 of INSMED Inc10
- Feb 3, 2026Sold 791 shares at $156.17 of INSMED Inc11
- Jan 8, 2026Sold 2,059 shares at $174.17 of INSMED Inc12
- Jan 7, 2026Sold 802 shares at $175.07 of INSMED Inc12
- Jan 6, 2026Sold 1,429 shares at $173.33 of INSMED Inc12
- Jan 2, 2026Granted 5,998 shares of INSMED Inc13
- Aug 19, 2025Sold 4,807 shares at $128.27 of INSMED Inc14
- Aug 19, 2025Sold 20,193 shares at $127.42 of INSMED Inc14
- Jun 16, 2025Sold 4,186 shares at $99.32 of INSMED Inc15
- Jun 16, 2025Sold 6,500 shares at $98.50 of INSMED Inc15
- Jun 3, 2025Sold 1,860 shares at $71.50 of INSMED Inc16
- May 15, 2025Granted 6,508 shares of INSMED Inc17
- May 14, 2025Sold 1,925 shares at $65.61 of INSMED Inc18
- May 13, 2025Sold 7,482 shares at $67.81 of INSMED Inc18
- Feb 10, 2025Sold 26,141 shares at $79.33 of INSMED Inc19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARDefinium Therapeutics, Board member
- 2SEC EDGARINSMED Inc, Chief operating officer
- 3SEC EDGARLandos Biopharma, Inc., Board member
- 4SEC EDGARINSMED Inc, Chief Commercial Officer
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 5, 2026
- 9SEC EDGARForm 4 filed May 15, 2026
- 10SEC EDGARForm 4 filed Apr 3, 2026
- 11SEC EDGARForm 4 filed Feb 4, 2026
- 12SEC EDGARForm 4 filed Jan 8, 2026
- 13SEC EDGARForm 4 filed Jan 6, 2026
- 14SEC EDGARForm 4 filed Aug 21, 2025
- 15SEC EDGARForm 4 filed Jun 18, 2025
- 16SEC EDGARForm 4 filed Jun 4, 2025
- 17SEC EDGARForm 4 filed May 19, 2025
- 18SEC EDGARForm 4 filed May 15, 2025
- 19SEC EDGARForm 4 filed Feb 12, 2025